Hisahide Nishio
Overview
Explore the profile of Hisahide Nishio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
1279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nambu Y, Matsumura T, Machida K, Tsutsumi R, Hata S, Shinkai-Ouchi F, et al.
Muscle Nerve
. 2025 Jan;
71(3):442-445.
PMID: 39777416
Introduction: A 20 kDa fragment at the N-terminus of titin is highly excreted in the urine of patients with Duchenne muscular dystrophy (DMD), making urine titin a prominent biomarker for...
2.
Ashida D, Nishio H, Fujiwara M, Iwai N
J Phys Ther Sci
. 2024 Dec;
36(12):765-771.
PMID: 39624351
[Purpose] To analyze the correlation between the timed up-and-go time and functional independence measure total score in postoperative elderly patients with vertebral and hip fractures. [Participants and Methods] The total...
3.
Nishio H, Niba E, Saito T, Okamoto K, Lee T, Takeshima Y, et al.
Genes (Basel)
. 2024 Oct;
15(10).
PMID: 39457418
Background: Spinal muscular atrophy (SMA) is a genetic disease characterized by loss of motor neurons in the spinal cord and lower brainstem. The term "SMA" usually refers to the most...
4.
Yamada M, Maeta K, Suzuki H, Kurosawa R, Takenouchi T, Awaya T, et al.
Sci Rep
. 2024 Mar;
14(1):6506.
PMID: 38499569
Pathogenic variants in WDR45 on chromosome Xp11 cause neurodegenerative disorder beta-propeller protein-associated neurodegeneration (BPAN). Currently, there is no effective therapy for BPAN. Here we report a 17-year-old female patient with...
5.
Nambu Y, Shirakawa T, Osawa K, Nishio H, Nozu K, Matsuo M, et al.
SAGE Open Med Case Rep
. 2024 Jan;
12:2050313X231221436.
PMID: 38187815
Becker muscular dystrophy is caused by mutations and is characterized by progressive muscle atrophy. The wide variations observed in muscle atrophy progression in Becker muscular dystrophy are considered multifactorial, including...
6.
Sonehara S, Bo R, Nambu Y, Iketani K, Lee T, Shimomura H, et al.
Genes (Basel)
. 2023 Dec;
14(12).
PMID: 38137033
Newborn screening (NBS) for spinal muscular atrophy (SMA) is necessary, as favorable outcomes can be achieved by treatment with disease-modifying drugs in early infancy. Although SMA-NBS has been initiated in...
7.
Bouike Y, Sakima M, Taninishi Y, Matsutani T, Noguchi Y, Bo R, et al.
Genes (Basel)
. 2023 Dec;
14(12).
PMID: 38136980
The survival motor neuron 2 () gene is a recognized modifier gene of spinal muscular atrophy (SMA). However, our knowledge about the role of -other than its modification of SMA...
8.
Maeta K, Farea M, Nishio H, Matsuo M
J Cachexia Sarcopenia Muscle
. 2023 Aug;
14(5):2289-2300.
PMID: 37582652
Background: Myostatin, encoded by the MSTN gene comprising 3 exons, is a potent negative regulator of skeletal muscle growth. Although a variety of myostatin inhibitors have been invented for increasing...
9.
Nishio H, Niba E, Saito T, Okamoto K, Takeshima Y, Awano H
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569314
Spinal muscular atrophy (SMA) is a lower motor neuron disease with autosomal recessive inheritance. The first cases of SMA were reported by Werdnig in 1891. Although the phenotypic variation of...
10.
Noguchi Y, Bo R, Nishio H, Matsumoto H, Matsui K, Yano Y, et al.
Genes (Basel)
. 2023 Mar;
14(3).
PMID: 36981045
The authors wish to make the following correction to this paper [...].